Dr. Ramya Dwivedi

Dr. Ramya Dwivedi

Feature Writer

Ph.D. Biotechnology

Ramya has a Ph.D. in Biotechnology from the National Chemical Laboratories (CSIR-NCL), in Pune. Her work consisted of functionalizing nanoparticles with different molecules of biological interest, studying the reaction system and establishing useful applications.

See more

She also has had exposure to research in molecular biology, immunology, evolutionary biology, chemistry, AFM imaging and analysis, and spectroscopy. Her interests cover interdisciplinary sciences.

She enjoyed teaching ‘Physics in Nanoscience and Nanotechnology’ as an Assistant Professor at SRM University. After a short period there, she pursued research further as the prestigious CSIR Nehru Science Post Doctoral Fellow in the field of Nanosciences.

Her research helped her skill for writing manuscripts, news articles, and reviews. She has also contributed as a peer reviewer for journals from RSC and ACS publications. After a maternity break and raising two daughters, Ramya is now working to get back into learning, research, and writing.

When Ramya is not immersed in a book, she loves to cook, travel and play with her daughters. She lives in Chennai. She is also a budding gardener. She strongly believes in doing her bit for the environment and in healthy living.

She has recently finished an online course: ‘Writing in the Sciences’, offered by Stanford University. Presently Ramya sees her freelance writing as a primer to her endeavors in science.

See less

Articles from Ramya

Engineered small extracellular vesicles for the neutralization of SARS-CoV-2

Engineered small extracellular vesicles for the neutralization of SARS-CoV-2

Association of obstructive sleep apnea with hospitalization due to COVID-19

Association of obstructive sleep apnea with hospitalization due to COVID-19

Oral bacteria-based SARS-CoV-2 vaccine platform

Oral bacteria-based SARS-CoV-2 vaccine platform

COVID-19 vaccine appears safe in children aged 5–11 Years

COVID-19 vaccine appears safe in children aged 5–11 Years

Recombinant adjuvanted zoster  vaccination associated with lower risk of COVID-19 diagnosis and hospitalization

Recombinant adjuvanted zoster vaccination associated with lower risk of COVID-19 diagnosis and hospitalization

SARS-CoV-2 Omicron variant neutralized by third BNT162b2 booster shot

SARS-CoV-2 Omicron variant neutralized by third BNT162b2 booster shot

Researchers report loss of antibody potency against SARS-CoV-2 Omicron variant

Researchers report loss of antibody potency against SARS-CoV-2 Omicron variant

Study reports that children develop sustained cross-reactive adaptive immunity against coronaviruses

Study reports that children develop sustained cross-reactive adaptive immunity against coronaviruses

Identifying a recurring pattern in broadly neutralizing antibodies that can target an epitope on SARS-CoV-2

Identifying a recurring pattern in broadly neutralizing antibodies that can target an epitope on SARS-CoV-2

Computational analysis of the effect of SARS-CoV-2 Omicron variant spike protein mutations

Computational analysis of the effect of SARS-CoV-2 Omicron variant spike protein mutations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.